LON:OPTI OptiBiotix Health (OPTI) Share Price, News & Analysis GBX 6.30 0.00 (0.00%) As of 07/13/2026 11:42 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About OptiBiotix Health Stock (LON:OPTI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OptiBiotix Health alerts:Sign Up Key Stats Today's Range 6.30▼ 6.5050-Day Range 4.80▼ 6.5052-Week Range 4.50▼ 13.50Volume71,771 shsAverage Volume407,103 shsMarket Capitalization£6.51 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness. OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks. OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes. This communication is a "Reach" announcement. Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach. Read More Receive OPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPTI Stock News HeadlinesOptibiotix Health Plc Share Price (OPTI.GB.PL)July 12 at 8:50 AM | lse.co.ukOptiBiotix Health (LON:OPTI) Stock Price Crosses Above Fifty Day Moving Average - Should You Sell?July 4, 2026 | americanbankingnews.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. | Porter & Company (Ad)OptiBiotix Improves Revenue and Margins as Focus Shifts Toward Sustainable Profitability (OPTI)May 28, 2026 | uk.finance.yahoo.comOptiBiotix to Present Upgraded SweetBiotix Sugar Alternative at London Shareholder Event (OPTI)May 14, 2026 | uk.finance.yahoo.comOptiBiotix shares rise after company says it will not sell SkinBioTherapeutics stakeFebruary 17, 2026 | finance.yahoo.comOptiBiotix Health hails record start to 2026 after securing new ordersJanuary 21, 2026 | lse.co.ukAIM WINNERS & LOSERS: OptiBiotix and Ixico rise on deal winsNovember 17, 2025 | lse.co.ukSee More Headlines OPTI Stock Analysis - Frequently Asked Questions How have OPTI shares performed this year? OptiBiotix Health's stock was trading at GBX 6.61 at the beginning of the year. Since then, OPTI stock has decreased by 4.7% and is now trading at GBX 6.30. How were OptiBiotix Health's earnings last quarter? OptiBiotix Health Plc (LON:OPTI) announced its quarterly earnings data on Thursday, May, 28th. The company reported ($3.84) earnings per share for the quarter. The firm had revenue of $1.17 million for the quarter. OptiBiotix Health had a negative trailing twelve-month return on equity of 52.92% and a negative net margin of 333.62%. How do I buy shares of OptiBiotix Health? Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of OptiBiotix Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO). Company Calendar Last Earnings5/28/2026Today7/13/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolLON:OPTI Previous SymbolLON:CMI CIKN/A Webwww.optibiotix.com Phone+44-20-79338780FaxN/AEmployees1Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (3.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£3.09 million Net Margins-333.62% Pretax MarginN/A Return on Equity-52.92% Return on Assets-13.93% Debt Debt-to-Equity RatioN/A Current Ratio4.27 Quick Ratio7.89 Sales & Book Value Annual Sales£1.17 million Price / Sales5.58 Cash FlowGBX 0.73 per share Price / Cash Flow8.68 Book ValueGBX 7.80 per share Price / Book0.81Miscellaneous Outstanding Shares103,300,000Free FloatN/AMarket Cap£6.51 million OptionableNot Optionable Beta1.85 Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (LON:OPTI) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThey told you not to miss this oneThe largest companies in the SP 500 are now more overvalued relative to fundamentals than they were at the abs...Thor Metals | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredPrint this and keep it by your screenEver been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...Profits Run | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptiBiotix Health Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share OptiBiotix Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
